Source:http://linkedlifedata.com/resource/pubmed/id/16300182
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-11-22
|
pubmed:abstractText |
The pharmacokinetics of diminazene aceturate following intramuscular (i.m.) administration at 4.2 mg/kg was evaluated in 8 healthy German Shepherd dogs. Blood samples were collected at 19 intervals over a period of 21 days. Diminazene plasma concentrations were measured using a validated HPLC method with UV detection and a sensitivity of 25 ng/ml. The in vitro and in vivo binding of diminazene to blood elements was additionally determined. Diminazene pharmacokinetics showed a large inter-individual variation after i.m. administration. It had a short absorption half-life (K01-HL of 0.11 +/- 0.18 h), resulting in a C(max) of 1849 +/- 268.7 ng/ml at T(max) of 0.37 h and a mean overall elimination half-life (T1/2beta) of 5.31 +/- 3.89 h. A terminal half-life of 27.5 +/- 25.0 h was measured. At 1 h after i.m. injection, 75% of the diminazene in whole blood was in the plasma fraction. The results of this study indicate that diminazene is rapidly distributed and sequestered into the liver, followed by a slower terminal phase during which diminazene is both redistributed to the peripheral tissues and/or renally excreted. It is recommended that diminazene administered i.m. at 4.2 mg/kg should not be repeated within a 21-day period.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1019-9128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
146-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16300182-Absorption,
pubmed-meshheading:16300182-Animals,
pubmed-meshheading:16300182-Chromatography, High Pressure Liquid,
pubmed-meshheading:16300182-Diminazene,
pubmed-meshheading:16300182-Dogs,
pubmed-meshheading:16300182-Half-Life,
pubmed-meshheading:16300182-Injections, Intramuscular,
pubmed-meshheading:16300182-Kidney,
pubmed-meshheading:16300182-Liver,
pubmed-meshheading:16300182-Male,
pubmed-meshheading:16300182-Tissue Distribution,
pubmed-meshheading:16300182-Trypanocidal Agents
|
pubmed:year |
2005
|
pubmed:articleTitle |
The pharmacokinetics of diminazene aceturate after intramuscular administration in healthy dogs.
|
pubmed:affiliation |
Department of Companion Animal Studies, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|